News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Finds "Serious Flaws" In Recent Study Doubting Tamiflu's Effectiveness


7/1/2014 6:04:26 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Roche said it found "many shortcomings" in what it described as a "seriously flawed" review of neuraminidase inhibitors published recently in the BMJ that questioned the effectiveness of its influenza drug Tamiflu (oseltamivir), the Financial Times reported Monday. According to Daniel Thurley, Roche's medical director in the UK, researchers at The Cochrane Collaboration who conducted the study "appear not to have understood how Tamiflu works" and also failed to consider all the data available to them.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
Roche
 
 
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES